PSYCHIATRIC ASPECTS IN PARKINSONISM TREATED WITH L-DOPA

[1] BARAHONAFERNAND.HJ, 1970, INT PHARMACOPSYCH, V3, P94

[2] BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[3] CALNE DB, 1969, LANCET, V2, P973

[4] CALNE DB, 1969, LANCET, V1, P744

[5] PSYCHOSIS AND OTHER PSYCHIATRIC MANIFESTATIONS OF LEVODOPA THERAPY [J]. ARCHIVES OF NEUROLOGY, 1970, 23 (03) : 193 - &

[6] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) : 337 - &

[7] DAMASIO AR, 1970, LANCET, V2, P611

[8] GOODWIN FK, 1970, LANCET, V1, P908

[9] HOEHN HM, 1967, NEUROLOGY MINNEAP, V17, P427

[10] JENKINS RB, 1970, LANCET, V2, P177

[1] BARAHONAFERNAND.HJ, 1970, INT PHARMACOPSYCH, V3, P94

[2] BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[3] CALNE DB, 1969, LANCET, V2, P973

[4] CALNE DB, 1969, LANCET, V1, P744

[5] PSYCHOSIS AND OTHER PSYCHIATRIC MANIFESTATIONS OF LEVODOPA THERAPY [J]. ARCHIVES OF NEUROLOGY, 1970, 23 (03) : 193 - &

[6] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) : 337 - &

[7] DAMASIO AR, 1970, LANCET, V2, P611

[8] GOODWIN FK, 1970, LANCET, V1, P908

[9] HOEHN HM, 1967, NEUROLOGY MINNEAP, V17, P427

[10] JENKINS RB, 1970, LANCET, V2, P177